In a study with hypertensive and/or diabetic patients with obesity and high levels of inflammatory markers, AA supplementation significantly reduced the concentrations of C-reactive protein (CRP), IL-6, fasting blood glucose, and triglyceride in blood than the AA-untreated group (Ellulu et al. 2015). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.